Genky DrugStores Co., Ltd.

TSE:9267.T

3610 (JPY) • At close May 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 184,860169,059154,639.641142,376.114123,603.493103,897.3194,869.23583,399.63473,495.98263,143.69357,949.84154,656.38356,700.82251,516.8941,247.85136,925.59832,728.548
Cost of Revenue 147,239134,505123,685.308112,086.65396,891.26679,478.20172,972.03663,974.97657,302.83949,272.72845,843.27843,866.82544,944.58840,787.49132,482.77728,951.66525,736.976
Gross Profit 37,62134,55430,954.33330,289.46126,712.22724,419.10921,897.19919,424.65816,193.14313,870.96512,106.56310,789.55811,756.23410,729.3998,765.0747,973.9336,991.572
Gross Profit Ratio 0.2040.2040.20.2130.2160.2350.2310.2330.220.220.2090.1970.2070.2080.2120.2160.214
Reseach & Development Expenses 00000000000000000
General & Administrative Expenses 000022,370.49620,372.28517,768.37615,575.57313,537.87911,132.03910,204.9589,893.00200000
Selling & Marketing Expenses 00002,081000000000000
SG&A 23,51823,19421,00019,91322,370.49620,372.28517,768.37615,575.57313,537.87911,132.03910,204.9589,893.00200000
Other Expenses 5,088431436.818352.315275.883293.978308.372286.949281.2187.268157.396195.668446.808413.969314.079151.849107.212
Operating Expenses 28,60627,84425,279.32123,994.50522,370.49620,372.28517,768.37615,575.57313,537.87911,132.03910,204.9589,893.00210,084.3629,378.4277,800.6357,023.4785,819.969
Operating Income 9,0166,7095,675.0116,294.9554,341.734,046.8234,128.8213,849.0842,655.2632,738.9241,901.604896.5551,671.8711,350.97964.438950.4541,171.602
Operating Income Ratio 0.0490.040.0370.0440.0350.0390.0440.0460.0360.0430.0330.0160.0290.0260.0230.0260.036
Total Other Income Expenses Net -213-5408.77368.017-309.598-160.589210.551240.923211.645102.7492.42120.256133.03251.196195.06834.044376.891
Income Before Tax 8,8036,7046,083.776,662.9724,032.1323,886.2344,339.3724,090.0072,866.9082,841.6641,994.0241,016.8112,056.721,602.1661,159.506984.4981,548.493
Income Before Tax Ratio 0.0480.040.0390.0470.0330.0370.0460.0490.0390.0450.0340.0190.0360.0310.0280.0270.047
Income Tax Expense 2,4781,9391,663.1021,831.3161,277.1081,188.6691,221.0751,244.263965.5551,080.334822.892393.746912.531697.942503.411504.294647.766
Net Income 6,3244,7644,4204,831.6552,755.0242,697.5643,118.2972,845.7441,901.3521,761.3291,171.132623.0651,144.188904.224656.095480.204900.726
Net Income Ratio 0.0340.0280.0290.0340.0220.0260.0330.0340.0260.0280.020.0110.020.0180.0160.0130.028
EPS 207.94156.89145.59159.1590.7687.35103.26100.8767.4763.0542.3822.641.6232.9226.4519.697,386.88
EPS Diluted 207.91156.79145.44159.0190.7687.35103.26100.8767.4762.5541.8822.3241.0432.6726.2819.587,292.63
EBITDA 14,47411,72910,734.93910,777.177,855.3377,255.7177,289.9036,766.4355,126.254,461.3043,517.4912,438.7113,277.8742,691.182,088.6461,773.6011,780.256
EBITDA Ratio 0.0780.0690.0690.0760.0640.070.0770.0810.070.0710.0610.0450.0580.0520.0510.0480.054